Promising news from DEA

Promising news from DEA. DEA has now scheduled an inspection of Dr. Mithoefer’s facility on October 28, by agents from both the regional DEA office and the South Carolina Bureau of Drug Control. …

Nature publishes a short news story

Nature publishes a short news story (PDF and HTML) on the MAPS sponsored MDMA/PTSD study. Nature 425, 552 (09 October 2003) MAPS has a few comments on the article.

MAPS Submits FOIA Request to NIDA

MAPS receives a confirmation letter from NIDA’s Freedom of Information Act (FOIA) staff that it has received our request for specific information about the studies that Drs. Ricaurte et al. conducted …

Triumph

The Institutional Review Board (IRB) reviewing Dr. Mithoefer’s MDMA/PTSD protocol made its final decision — and approved the study! This is a historic moment for MAPS and for MDMA research. …

MAPS Sent a Letter to NIDA Director Nora Volkow

MAPS sends a letter to NIDA Director Nora Volkow noting the many unanswered questions in the Ricaurte et al. retraction and requesting the release of additional information. MAPS states that the credibility …

Another Independent IRB

For the last several months, another independent Institutional Review Board (IRB) has been reviewing Dr. Michael Mithoefer’s MAPS -sponsored MDMA/PTSD protocol. Today, we submitted our response to …

Drs. Mithoefer, Jerome and Doblin have written a letter

Drs. Mithoefer, Jerome and Doblin have written a reply to the Ricaurte et al. letter published in Science on June 6, 2003. We have submitted our reply to Drs. Ricaurte and McCann and indicated that we …